# Jumpei Kashima

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jumpei-kashima/

## Facts

| Field | Value |
| --- | --- |
| Citations | 919 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 16 |
| i10-index | 22 |
| Last Known Institution | University Hospital of Basel |
| OpenAlex ID | https://openalex.org/A5066856332 |
| ORCID iD | 0000-0002-5225-9319 |
| Works | 72 |

## Researcher papers

- [Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung](https://scholariq.org/papers/long-term-prognosis-of-patients-with-resected-adenocarcinoma-in-situ-and/)
- [Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System](https://scholariq.org/papers/clinicopathologic-and-genotypic-features-of-lung-adenocarcinoma-characterized-by/)
- [Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report](https://scholariq.org/papers/bile-duct-obstruction-in-a-patient-treated-with-nivolumab-as-second-line/)
- [Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and Oncologists](https://scholariq.org/papers/molecular-and-morphological-profiling-of-lung-cancer-a-foundation-for-next/)
- [Immunohistochemical study of the autophagy marker microtubule‐associated protein 1 light chain 3 in normal and steatotic human livers](https://scholariq.org/papers/immunohistochemical-study-of-the-autophagy-marker-microtubule-associated-protein/)
- [Prognostic Impact of the Histologic Lepidic Component in Pathologic Stage IA Adenocarcinoma](https://scholariq.org/papers/prognostic-impact-of-the-histologic-lepidic-component-in-pathologic-stage-ia/)
- [ALK-positive Histiocytosis of the Breast](https://scholariq.org/papers/alk-positive-histiocytosis-of-the-breast/)
- [The Isoform Matters in NUT Carcinoma: A Diagnostic Pitfall of p40 Immunohistochemistry](https://scholariq.org/papers/the-isoform-matters-in-nut-carcinoma-a-diagnostic-pitfall-of-p40/)
- [A case report of cutaneous melanocytoma with <i>CRTC1‐TRIM11</i> fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?](https://scholariq.org/papers/a-case-report-of-cutaneous-melanocytoma-with-i-crtc1-trim11-i-fusion-is-cmct/)
- [Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report](https://scholariq.org/papers/re-challenging-immune-checkpoint-inhibitor-in-a-patient-with-advanced-non-small/)
- [EP.06B.14 Differential Expression in Potential Therapeutic Target Protein by Treatment in Small Cell Lung Cancer with and without Transformation](https://scholariq.org/papers/ep-06b-14-differential-expression-in-potential-therapeutic-target-protein-by/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)

## Researcher university

- [University Hospital of Basel](https://scholariq.org/institutions/university-hospital-of-basel/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.